Your search returned 5 results.

Sort
Results
1.
Deleterious BRCA1/2 mutations in an urban population of Black women. MedStar authors:
  • Fries, Melissa
  • Lynce, Filipa
PMID:
  • 26250392
Year: 2015
Citation:
  • Breast Cancer Research & Treatment. 153(1):201-9, 2015 Aug.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • DeMarco T, Fries M, Isaacs C, Lynce F, Peshkin BN, Smith KL, Stein J, Wang H, Wang Y
2.
BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. MedStar authors:
  • Lynce, Filipa
  • Schlam, Ilana
PMID:
  • 33010199
Year: 2021
Citation:
  • Journal of Genetic Counseling. 30(2):383-393, 2021 04.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahn J, Campos C, Denduluri N, Dutil J, Friedman S, Geng X, Graves KD, Isaacs C, Lynce F, Nahleh Z, Peshkin BN, Ricker C, Rodriguez P, Schlam I
3.
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer. MedStar authors:
  • Blackburn, Matthew J
  • Chitalia, Ami
  • Dilawari, Asma
  • Gallagher, Christopher
  • Lynce, Filipa
  • Mohebtash, Mahsa
  • Tiwari, Shruti R
PMID:
  • 34157782
Year: 2021
Citation:
  • Cancer. 127(19):3622-3630, 2021 10 01.
Institution:
  • MedStar Franklin Square Cancer Center at Loch Raven Campus
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Hematology & Oncology Fellowship
  • Hematology and Oncology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abu-Khalaf M, Blackburn MJ, Chitalia A, Dilawari A, Gallagher C, Hahn OM, Isaacs C, Lynce F, Mohebtash M, Pohlmann PR, Shajahan-Haq AN, Tan M, Tiwari SR, Warren R, Wu T, Zhuo R
4.
Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Herbolsheimer, Pia M
  • Lynce, Filipa
  • Mete, Mihriye
  • Nunes, Raquel
  • Shara, Nawar M
  • Swain, Sandra M
  • Wray, Lynette
PMID:
  • 26749359
Year: 2016
Citation:
  • Breast Cancer Research & Treatment. 155(2):285-93, 2016 Jan.
Institution:
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
  • Washington Cancer Institute
  • Washington Cancer Institute A
  • Washington Cancer Instituteia
Department:
  • MedStar Heart Institute
  • MedStar Heart Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Herbolsheimer P, Isaacs C, Lynce F, Mete M, Nardacci MP, Nunes RA, Peshkin BN, Shara NM, Smith KL, Swain SM, Warren R, Wray L
5.
SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. MedStar authors:
  • Asch, Federico M
  • Barac, Ana
  • Lynce, Filipa
  • Swain, Sandra M
PMID:
  • 28314836
Year: 2017
Citation:
  • Oncologist. 22(5):518-525, 2017 May
Institution:
  • MedStar Heart & Vascular Institute
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Asch FM, Barac A, Dang C, Isaacs C, Lynce F, Smith KL, Swain SM, Tan MT
Pages

Powered by Koha